Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

16:05 ET Windtree Receives $0.7 Million SBIR Grant in Continuing Support of the AEROSURF® Phase 2b Clinical Trial Completion

Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory...


13:31 ET Prometic presents new clinical data on PBI-4050 for the treatment of idiopathic pulmonary fibrosis

- Treatment with PBI-4050 for 12 weeks positively affected biomarkers known to have antifibrotic activity - New clinical data presented...


12:57 ET Wize Pharma Announces Presentation of New Data on LO2A in the Treatment of Dry Eye Syndrome in Patients with Sjögren's Syndrome

Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced today that...


11:35 ET Lift Heavier, Run Faster and Get Leaner…With a Sleep Coach?

Equinox, the high-performance lifestyle leader, today unveiled a study led with researchers at the David Geffen School of Medicine at UCLA linking...


10:55 ET UsAgainstAlzheimer's Statement on Alzheimer's Drug Development

UsAgainstAlzheimer's Chairman George Vradenburg today issued the following statement regarding the termination of clinical trial testing of the...


10:12 ET Linköping University Hospital Second Swedish Site in Largest Ever Prospective Multicenter Clinical Study for Early Detection of Pancreatic Cancer

Immunovia AB today announced that Linköping University Hospital is to participate in PanFAM-1, the largest ever prospective study looking at early...


09:30 ET Eisai and Purdue Pharma Announce Key Phase 1 Clinical Studies of Lemborexant to be Presented at the 32nd Annual SLEEP Meeting

Companies will present data on: - Postural stability after middle-of-the-night awakening and next-morning compared to zolpidem ER -...


09:29 ET Longeveron Receives TEDCO Grant To Fund Stem Cell Research

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related conditions, announced that it has received a...


09:03 ET Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care...


09:00 ET National Institutes of Health Awards Envisagenics with $1.5M Phase II SBIR Grant

Envisagenics, Inc., a New York based biotechnology company, announced today that it was awarded a Small Business Innovation Research (SBIR) Phase...


08:30 ET Lilly's Taltz® (ixekizumab) Receives the First U.S. FDA Approval for Label Update to Include Data for Psoriasis Involving the Genital Area

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label update for Taltz®...


08:30 ET Ampio Updates Scientific presentations and publications on Ampion™

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a poster presentation on the mechanism of action of a component of Ampion™ will be...


08:30 ET Global Alzheimer's Platform Foundation Comments On Janssen's Termination of The EARLY Study of Atabecestat

On Thursday, May 17, Janssen announced the termination of the EARLY clinical trial investigating a BACE inhibitor, atabecestat. The goal of this...


08:30 ET Anuncia Announces Successful First-in-Human Use of the Alivio ReFlow™ Ventricular System for Treatment of Hydrocephalus

Anuncia, Inc., a privately-held company focused on better treatment of hydrocephalus and cerebrospinal fluid dysfunctions, announced, today, the...


08:05 ET Vast Therapeutics (formerly Novoclem) Announces Results Showing Eradication of all In Vitro Tested Multi-Drug Resistant Bacteria and a 99% Reduction of Nontuberculous Mycobacteria (NTM) in Animal Model.

Vast Therapeutics, Inc., formerly Novoclem Therapeutics, Inc. (the Company), a preclinical stage pharmaceutical company focused on delivering the...


08:01 ET FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes

The U.S. Food and Drug Administration (FDA) has accepted Sanofi's regulatory filing for Zynquista (sotagliflozin). The investigational oral...


08:00 ET Epic Sciences Presents Single Cell Genomics Data at 10th DIA China Annual Meeting

Epic Sciences announced today that new data will be presented from studies utilizing its single cell sequencing of circulating tumor cells (CTCs)...


07:30 ET BioMarin Provides 2 Years of Clinical Data in 6e13 vg/kg Dose from Ongoing Phase 1/2 Study in Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A at World Federation of Hemophilia 2018 World Congress

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today an update to its previously reported results of an open-label Phase 1/2 study of...


07:00 ET Check-Cap Announces Publication of CE Mark Multicenter Clinical Study Results on C-Scan® in Gut

Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company engaged...


05:00 ET Renowned African Research Institutes Join Pediatric Praziquantel Consortium

Complementary experience offered by the Kenya Medical Research Institute (KEMRI) and the Université Félix Houphouët-Boigny (UFHB) in conducting...


02:00 ET FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR and Received USA 510(k) Market Clearance

A highly innovative software, developed by Pie Medical Imaging - PMI - B.V. (Esaote Group) will be presented at EuroPCR 2018, the world-leading...


02:00 ET Lo studio clinico FAST dimostra elevata accuratezza diagnostica del software CAAS vFFR, che ha ricevuto dagli Stati Uniti l'autorizzazione alla commercializzazione FDA 510 (k)

Un software altamente innovativo, sviluppato da Pie Medical Imaging - PMI - BV (Gruppo Esaote) sarà presentato al congresso EuroPCR 2018, il...


02:00 ET L'étude FAST fait la preuve de la haute précision diagnostique du CAAS vFFR qui obtient le feu vert 510(k) de la FDA pour sa mise sur le marché.

Un logiciel hautement innovant, développé par PMI (Pie Medical Imaging B.V.) sera présenté à l'EuroPCR 2018, l'événement de renommée mondiale...


02:00 ET FAST-Studie weist hohe Diagnosegenauigkeit von CAAS vFFR nach und erhält die 510(k)-Zulassung in den USA

Eine von Pie Medical Imaging - PMI - B.V. entwickelte hoch innovative Software wird beim EuroPCR 2018, der international führenden...


00:28 ET Nobles Medical Technologies II Showcases Noblestitch™ PFO Closure At EuroPCR

NMT2 announces it will be featured at the 2018 EUROPCR Congress in Paris, France. The annual assembly, which again takes place at the Palace de...